![Jolanta Airey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: - $ as of 30/05/2026
Dr. Jolanta Airey is a Chief Medical Officer at Cynata Therapeutics Ltd. Dr. Airey was previously employed as a Director-Translational Development by CSL Ltd. and a Head-Clinical Development Physician by Csl Seqirus.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 29/06/2025 | 0 ( -.--% ) | - $ | 30/05/2026 |
| Companies | Position | Start |
|---|---|---|
| CYNATA THERAPEUTICS LIMITED | Chief Tech/Sci/R&D Officer | 10/10/2021 |
| Companies | Position | End |
|---|---|---|
| CSL LIMITED | Corporate Officer/Principal | 30/09/2021 |
Csl Seqirus | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 3 |
|---|---|
CSL Ltd.
 CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Cynata Therapeutics Ltd.
 Cynata Therapeutics Ltd. BiotechnologyHealth Technology Engages in stem cell research and development services | Health Technology |
Csl Seqirus | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
Choose MarketScreener 
